L. Karmani, V. Bouchat, C. Bouzin, P. Leveque, D. Labar, A. Bol, G. Deumer, R. Marega, D. Bonifazi, V. Haufroid, C. Michiels, V. Gregoire, O. Feron, S. Lucas, T. Vander Borght, B. Gallez,
Nanomedicine (London, U. K.) 2014, 9, 1923-1937
Antibody-labeled gold nanoparticles represent an attractive tool for cancer imaging and therapy. In this study, the anti-CD105 antibody was conjugated with gold nanoparticles (AuNPs) for the first time. The antibody biodistribution in mice before and after conjugation to AuNPs was studied, with a focus on tumor targeting.